Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method for the diagnosis of brain/neurological disease using monoclonal antibodies specific for PHF-tau, hybridomas secreting them, and antigen recognition by these antibodies and their applications

Method for the diagnosis of brain/neurological disease using monoclonal antibodies specific for PHF-tau, hybridomas secreting them, and antigen recognition by these antibodies and their applications

US Patent 6500674 · Granted Dec 31, 2002

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods of binding amyloid beta protein having pyroglutamate at the third amino 2023
Methods of detecting pyroglutamate amyloid beta protein (3pE Aβ) using anti-3pE 2020
Antibodies to pyroglutamate amyloid-β and uses thereof2019
Anti-PHG-tau antibodies and their uses2019
Anti-PHF-tau antibodies and their uses2018
N-11 truncated amyloid-beta monoclonal antibodies, compositions, methods and use2018
Anti-PHF-tau antibodies and their uses2017
Antibodies to phosphorylated tau aggregates2016
Anti-PHF-tau antibodies and their uses2016
N-11 truncated amyloid-beta Aβ11-x monoclonal antibodies and compositions2016
Monoclonal antibodies specific for beta-amyloid x-37 and uses thereof2014
Antibodies specific of the β-amyloid peptides and their uses as diagnostic agent2013